Chemotherapy of prostate cancer: Present and future
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-003-0074-3.pdf
Reference33 articles.
1. Kantoff PW, Halabi S, Conaway M, et al.: Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol 1999, 17:2506–2513.
2. Tannock IF, Osoba D, Stockler MR, et al.: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996, 14:1756–1764.
3. Hudes G, Einhorn L, Ross E, et al.: Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: a Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol 1999, 17:3160–3166.
4. Oh WK, Kantoff PW: Management of hormone refractory prostate cancer: current standards and future prospects. J Urol 1998, 160:1220–1229.
5. Culine S, Droz JP: Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: a decade of progress? Ann Oncol 2000, 11:1523–1530. A good review article that can improve our understanding of the evolvement of chemotherapy in prostate cancer.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug Resistance and Cardiovascular Safety of Second-Generation Anti-Androgens in Patients with Advanced Prostate Cancer;Galen Medical Journal;2023-12-26
2. Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies;Journal of Controlled Release;2021-05
3. Cancer stem cells—clinical relevance;Journal of Molecular Medicine;2009-10-10
4. Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer;Dermato-Endocrinology;2009-01
5. ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology;Current Medicinal Chemistry;2008-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3